drugset / Trial / NCT02620631

Study to Examine Pain Relief With Supplemental Intrathecal Morphine in TKA Patients

NCT02620631

Phase 4 Unknown 54 enrolled Stony Brook University
RandomizedParallel-groupQuadruple-blind

Summary

This is a prospective, randomized, double-blinded, placebo-controlled study designed to examine pain relief following intrathecal morphine sulfate (0.2mg) in patients undergoing total knee arthroplasty (TKA) under spinal anesthesia in addition to a femoral nerve catheter. The protocol consists of two parts: (1) a prospective patient recruitment study and (2) a retrospective assay for endocannabinoids on previously collected specimens.

Timeline

Start
2011-03
Primary completion
2014-02
Completion
2017-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Morphine Other / unclassified 0.2 mg Intrathecal

Indications

No indication recorded.